These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 286190)

  • 1. Therapy of acute nonlymphocytic leukemia: I. Clinical aspects.
    Preisler HD; Higby DJ
    N Y State J Med; 1979 May; 79(6):879-84. PubMed ID: 286190
    [No Abstract]   [Full Text] [Related]  

  • 2. Advances in the management of acute nonlymphocytic leukemia.
    Wiernik PH
    Arch Intern Med; 1976 Dec; 136(12):1399-403. PubMed ID: 826228
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapy of acute nonlymphocytic leukemia: 2. Biological characteristics and prediction of response.
    Preisler HD; Rustum YM; Epstein J
    N Y State J Med; 1979 May; 79(6):885-9. PubMed ID: 286191
    [No Abstract]   [Full Text] [Related]  

  • 4. Sequential studies of daunorubicin and adriamycin in acute nonlymphocytic leukemia.
    Wiernik PH
    Cancer Treat Rep; 1981; 65 Suppl 4():67-71. PubMed ID: 7049382
    [No Abstract]   [Full Text] [Related]  

  • 5. Adriamycin-cytosine arabinoside therapy for adult acute myelocytic leukemia.
    Preisler HD; Bjornsson S; Henderson ES
    Cancer Treat Rep; 1977; 61(1):89-92. PubMed ID: 324625
    [No Abstract]   [Full Text] [Related]  

  • 6. Progress in the treatment of adults with acute leukemia: review of regimens containing cytarabine studied by the Southwest Oncology Group.
    Bodey GP; Coltman CA; Hewlett JS; Freireich EJ
    Arch Intern Med; 1976 Dec; 136(12):1383-8. PubMed ID: 1069570
    [No Abstract]   [Full Text] [Related]  

  • 7. [Advances in the treatment of acute leukemia in adults].
    Pawelski S
    Acta Haematol Pol; 1973; 4(4):283-9. PubMed ID: 4772918
    [No Abstract]   [Full Text] [Related]  

  • 8. Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial.
    Pedersen-Bjergaard J; Brincker H; Ellegaard J; Drivsholm A; Freund L; Jensen KB; Jensen MK; Nissen NI
    Cancer Treat Rep; 1984 Oct; 68(10):1233-8. PubMed ID: 6597002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy for adult acute nonlymphocytic leukemia with daunorubicin and cytosine arabinoside.
    Cassileth PA; Katz ME
    Cancer Treat Rep; 1977 Nov; 61(8):1441-5. PubMed ID: 922749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction therapy and intensive consolidation with daunorubicin, cytosine arabinoside, and 6-thioguanine in adult acute nonlymphoblastic leukemia.
    Cassileth PA; Kahn SB; Silber R; Weiler C
    Cancer Clin Trials; 1981; 4(2):125-8. PubMed ID: 7249250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approaches to the treatment of acute leukemia and lymphoma in adults.
    Bodey GP; Rodriguez V
    Semin Hematol; 1978 Jul; 15(3):221-61. PubMed ID: 353991
    [No Abstract]   [Full Text] [Related]  

  • 12. Treating acute nonlymphocytic leukemia.
    Richert-Boe KE; Bagby GC
    Geriatrics; 1978 Feb; 33(2):50-5. PubMed ID: 620934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic results in patients with acute leukemia].
    Wilms K; Haen M; Rückle H; Maulbetsch R; Waller HD
    Verh Dtsch Ges Inn Med; 1978; (84):159-63. PubMed ID: 742029
    [No Abstract]   [Full Text] [Related]  

  • 14. Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia.
    Wiernik PH; Schimpff SC; Schiffer CA; Lichtenfeld JL; Aisner J; O'Connell MJ; Fortner C
    Cancer Treat Rep; 1976 Jan; 60(1):41-53. PubMed ID: 1069608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New drugs for the therapy of acute leukemia].
    Massimo L; Comelli A
    Minerva Med; 1975 Jul; 66(52):2568-76. PubMed ID: 50581
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acute adult leukemia. Therapeutic options including supportive measures].
    Jehn U; Wilmanns W
    MMW Munch Med Wochenschr; 1980 Apr; 122(14):494-8. PubMed ID: 6769025
    [No Abstract]   [Full Text] [Related]  

  • 17. Remission-induction, consolidation and maintenance therapy by AVA protocol in acute nonlymphoblastic leukemia.
    Torlontano G; Geraci L; Lombardo M; Di Marzio A; Iacone A; Fioritoni G; Bonanni G; Di Bartolomeo P; Ballone E; D'Antonio D; Di Girolamo G; D'Arcangelo L; Pandoli G; Natale D; Spadano A
    Haematologica; 1982 Apr; 67(2):230-45. PubMed ID: 6807770
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of acute leukemia in adults. Results with a combination of potent cytotoxic drugs.
    Stavem P; Gjemdal T
    Acta Med Scand; 1974; 196(1-2):121-5. PubMed ID: 4529548
    [No Abstract]   [Full Text] [Related]  

  • 19. Interhospital differences in the treatment of acute leukaemia in adults. The Finnish Leukaemia Group.
    Scand J Haematol; 1979 Aug; 23(2):119-23. PubMed ID: 386480
    [No Abstract]   [Full Text] [Related]  

  • 20. Proceedings: Treatment of acute leukaemia in adults.
    Vincent PC; Gunz FW; Levi JA
    Med J Aust; 1974 Jun; 1(26):1035-8. PubMed ID: 4527946
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.